Brain, Vol. 123, No. 7, 1339-1348,
July 2000
© 2000 Oxford University Press
Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis
1 Department of Neurology, 2 Institute of Neuropathology and 3 Institute of Medical Neurobiology, University of Magdeburg Medical Center, Magdeburg, 4 Institute of Clinical Chemistry, Medical Center of RWTH Aachen, Aachen and 5 Department of Epileptology, University of Bonn Medical Center, Bonn, Germany
Correspondence to:
Wolfram S. Kunz, Department of Epileptology, University of Bonn Medical Center, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany E-mail: kunz{at}mailer.meb.uni-bonn.de
Amyotrophic lateral sclerosis is a neurodegenerative disease affecting the anterior horn cells of the spinal cord and cortical motor neurons. Previous findings have suggested a specific impairment of mitochondrial function in skeletal muscle of at least a limited number of patients. Applying flavoprotein/NAD(P)H autofluorescence imaging of mitochondrial function in saponin-permeabilized muscle fibres, we detected a heterogeneous distribution of the respiratory chain defect among individual fibres in muscle biopsies of patients (11 out of 17) with sporadic amyotrophic lateral sclerosis (SALS). These findings correlate with the presence of cytochrome c oxidase (COX)-negative muscle fibres detected histologically. We established the molecular basis for the decreased activities of NADH:CoQ oxidoreductase and COX in SALS muscle. In the skeletal muscle of the investigated patients, diminished levels (13 out of 17) or multiple deletions (one out of 17) of mitochondrial DNA (mtDNA) were observed. These alterations of mtDNA seem to be related to decreased levels of membrane-associated mitochondrial Mn-superoxide dismutase. Our results support the viewpoint that an oxygen radical-induced impairment of mtDNA is of pathophysiological significance in the aetiology of at least a subgroup of patients with SALS.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. K. Jaiswal and B. U. Keller Cu/Zn Superoxide Dismutase Typical for Familial Amyotrophic Lateral Sclerosis Increases the Vulnerability of Mitochondria and Perturbs Ca2+ Homeostasis in SOD1G93A Mice Mol. Pharmacol., March 1, 2009; 75(3): 478 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fergani, H. Oudart, J.-L. Gonzalez De Aguilar, B. Fricker, F. Rene, J.-F. Hocquette, V. Meininger, L. Dupuis, and J.-P. Loeffler Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis J. Lipid Res., July 1, 2007; 48(7): 1571 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Krasnianski, M. Deschauer, M. Krasnianski, and S. Zierz Reply to 'Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies--a comment'. Brain, March 1, 2006; 129(Pt 3): E41 - E41. [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Schonhoff, M. Matsuoka, H. Tummala, M. A. Johnson, A. G. Estevéz, R. Wu, A.és Kamaid, K. C. Ricart, Y. Hashimoto, B. Gaston, et al. S-nitrosothiol depletion in amyotrophic lateral sclerosis PNAS, February 14, 2006; 103(7): 2404 - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vielhaber, C. Kornblum, H.-J. Heinze, C. E. Elger, and W. S. Kunz Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies--a comment Brain, December 1, 2005; 128(12): E38 - E38. [Full Text] [PDF]
|
|
|
|
|
|
A. Krasnianski, M. Deschauer, S. Neudecker, F. N. Gellerich, T. Muller, B. G. Schoser, M. Krasnianski, and S. Zierz Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies Brain, August 1, 2005; 128(8): 1870 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dupuis, H. Oudart, F. Rene, J.-L. G. de Aguilar, and J.-P. Loeffler Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model PNAS, July 27, 2004; 101(30): 11159 - 11164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schroder, B. Goudeau, M. C. Simon, D. Fischer, T. Eggermann, C. S. Clemen, Z. Li, J. Reimann, Z. Xue, S. Rudnik-Schoneborn, et al. On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria Hum. Mol. Genet., March 15, 2003; 12(6): 657 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Menzies, M. R. Cookson, R. W. Taylor, D. M. Turnbull, Z. M. A. Chrzanowska-Lightowlers, L. Dong, D. A. Figlewicz, and P. J. Shaw Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis Brain, July 1, 2002; 125(7): 1522 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A H V Schapira The "new" mitochondrial disorders J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Cluskey and D B Ramsden Mechanisms of neurodegeneration in amyotrophic lateral sclerosis Mol. Pathol., December 1, 2001; 54(6): 386 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Beal Mitochondria and the pathogenesis of ALS Brain, July 1, 2000; 123(7): 1291 - 1292. [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Kunz, A. Kudin, S. Vielhaber, C. E. Elger, G. Attardi, and G. Villani Flux Control of Cytochrome c Oxidase in Human Skeletal Muscle J. Biol. Chem., September 1, 2000; 275(36): 27741 - 27745. [Abstract] [Full Text] [PDF]
|
|